- Home
- BMY vs HCA Comparison
BMY vs HCA Comparison
Compare BMY & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- HCA
- Stock Information
- Founded
- BMY 1887
- HCA 1968
- Country
- BMY United States
- HCA United States
- Employees
- BMY N/A
- HCA N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- HCA Hospital/Nursing Management
- Sector
- BMY Health Care
- HCA Health Care
- Exchange
- BMY Nasdaq
- HCA Nasdaq
- Market Cap
- BMY 97.6B
- HCA 90.9B
- IPO Year
- BMY N/A
- HCA N/A
- Fundamental
- Price
- BMY $47.65
- HCA $377.88
- Analyst Decision
- BMY Hold
- HCA Buy
- Analyst Count
- BMY 16
- HCA 15
- Target Price
- BMY $58.33
- HCA $397.38
- AVG Volume (30 Days)
- BMY 14.1M
- HCA 1.4M
- Earning Date
- BMY 07-31-2025
- HCA 07-25-2025
- Dividend Yield
- BMY 5.21%
- HCA 0.76%
- EPS Growth
- BMY N/A
- HCA 12.23
- EPS
- BMY 2.67
- HCA 22.47
- Revenue
- BMY $47,636,000,000.00
- HCA $71,585,000,000.00
- Revenue This Year
- BMY N/A
- HCA $6.88
- Revenue Next Year
- BMY N/A
- HCA $5.18
- P/E Ratio
- BMY $17.84
- HCA $16.82
- Revenue Growth
- BMY 4.62
- HCA 7.30
- 52 Week Low
- BMY $39.71
- HCA $289.98
- 52 Week High
- BMY $63.33
- HCA $417.14
- Technical
- Relative Strength Index (RSI)
- BMY 50.53
- HCA 50.37
- Support Level
- BMY $46.33
- HCA $371.22
- Resistance Level
- BMY $47.82
- HCA $382.55
- Average True Range (ATR)
- BMY 0.84
- HCA 7.86
- MACD
- BMY 0.06
- HCA -0.69
- Stochastic Oscillator
- BMY 70.81
- HCA 30.07
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.